NCBiotech News

Durham global CRO BioAgilytix, one of North Carolina’s fastest-growing life sciences businesses, has announced plans to buy Australia’s 360biolabs.

Tara Cameron decided she wanted to transition from her career as a certified nursing assistant into a new position in the medical field, so she turned to Wake Tech’s BioWork certificate program and now loves her career as a technician at pharmaceutical manufacturer FUJIFILM Diosynth Biotechnologies in Morrisville.

Raleigh medical device startup Advanced Chemotherapy Technologies just got another $4 million in an NCI grant to advance its efforts to develop a targeted drug delivery system to attack pancreatic cancer.

NCBiotech and UNC FastTraCS are collaborating with health systems across the state to help health care providers turn good ideas into useful clinician innovation at the inaugural “Accelerating Heath Care Innovation in North Carolina: Charting the Course” virtual conference Sept. 23 and 24.

Flush with new cash, Morrisville contract services organization Kymanox has acquired Neuma, a drug delivery services provider founded in 2017 in King of Prussia, Pennsylvania.

RTP-based Agbiome has submitted a small- and large-molecule combination fungicide product candidate, Esendo, to the Environmental Protection Agency for review.

Peyton Howell of Paraxel International in Durham and Dave Oury of Medical Leverage in Cary were named to the PharmaVoice 100, an annual list that recognizes inspirational and innovative individuals who are making positive contributions to the life sciences

Metrics Contract Services, a full-service global contract development and manufacturing organization (CDMO) based in Greenville, has expanded its facilities for producing oral, solid-dose drugs.

A $441,028 grant from the National Science Foundation will help a group of educational institutions in the Piedmont Triad prepare a skilled workforce for jobs in regenerative medicine.

Six-year-old Marley enjoys playing with her toys and idolizes her older brother. However, it took a world of support, dozens of doctor’s visits, and a medical miracle that included Metabolon's precision diagnostics technology, to get here.

Tempus, a fast-growing artificial intelligence and precision medicine company, has established a new Durham lab, and plans to hire staff to fully occupy the 52,000-square foot site at 25 Parmer Way.

Global biopharmaceutical icon Amgen Inc. is building a $550 million manufacturing facility in Holly Springs that will employ 355 people

Bioventus, a global orthobiologics company headquartered in Durham, will acquire Misonix, a New York-based developer of ultrasonic surgical devices, in a cash-and-stock transaction valued at about $518 million.

The North Carolina Biotechnology Center awarded 21 grants and loans totaling more than $1.9 million to universities and biosciences companies and other entities in the fourth quarter of its fiscal year.

Seqirus, the global vaccine maker with a mega factory in Holly Springs, has just begun to ship its portfolio of seasonal flu vaccines to healthcare providers across the United States. It is prepared to supply approximately 60 million doses to meet demand for the 2021-2022 flu season.